6 Best Healthcare Stocks to Buy Right Now

10:11am, Tuesday, 25'th Apr 2023
The United States healthcare system includes two sectors: public endeavors like Medicare and Medicaid and private health insurance companies. Healthcare stocks represent a significant section of the U
Johnson & Johnson's sales and earnings moved higher in the first quarter. The company's payout ratio is manageable enough to support future dividend growth.
Investors have shown keen interest in biotech after Johnson & Johnson's (NYSE: JNJ ) impressive earnings beat that topped Wall Street's expectations. The earnings beat reignited enthusiasm for biotech
Are signs of life emerging from the moribund IPO market? If Johnson & Johnson (NYSE:JNJ)'s corporate advisors are correct, then, yes, possibly.
#Johnson&Johnson The Yahoo Finance Live team discusses the rise of Johnson & Johnson stock after a steady decline the past year, amid controversy regarding some products.
Johnson & Johnson JNJ expects to raise roughly $3 billion in an initial public offering of its consumer-health unit. In a filing with the Securities and Exchange Commission made public Monday afternoo
And we answer listener questions about retirement accounts, buying stock in your employer, and more.
The "Motley Fool Money" crew kicks things off with a look at what's going on with Netflix.

The 3 Greatest Dividend Stocks to Buy Now

01:22pm, Monday, 24'th Apr 2023
Investing in the stock market to derive a stable income in the form of dividends can be a complex task, with a myriad of options to choose from. The article explores the top three dividend companies w
Cancer victims on Monday urged a U.S. judge to dismiss a Johnson & Johnson subsidiary's second bankruptcy filing, saying that the company is abusing the bankruptcy system in its renewed attempt to res
Johnson & Johnson (JNJ) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
J&J's consumer health unit Kenvue aims to raise $3.5 billion or more in the initial public offering, sources told the Wall Street Journal.
We look at a few pharma/biotech companies, SNY, AMGN, REGN, ACAD, which are poised to beat on earnings in the first quarter.
Johnson & Johnson (NYSE:JNJ) is reportedly discussing the spin-off and initial public offering (IPO) of its consumer business Kenvue with investors, in a move set to test the waters of the subdued mar
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE